In the third quarter, Abbington Investment Group established a new stake in Albemarle Corporation by acquiring 4,107 shares at an aggregate cost of approximately $333,000, according to the firm’s latest 13F filing with the SEC. This marks the first reported holding of Albemarle by Abbington, reflecting confidence in the specialty chemicals producer’s portfolio, particularly its lithium and bromine segments.

Institutional ownership of Albemarle surged during the second quarter, with ProShare Advisors increasing its position by 48.5% to roughly 2.87 million shares, and AQR Capital Management boosting its stake by over 22,000%, now holding 713,812 shares. PGGM Investments grew its holdings by 90.4% to 1.07 million shares, while newcomers FengHe Fund Management and Norges Bank each initiated positions valued at nearly $33 million and $29.5 million, respectively. Together, hedge funds and other large investors now control 92.87% of Albemarle’s outstanding stock.

Analyst coverage of Albemarle spans 31 firms, with two assigning a Strong Buy, ten a Buy, seventeen a Hold and two a Sell. Recent research notes include upgrades by several major banks, underscoring expectations for lithium market recovery and cost discipline. While the consensus remains a Hold, the breadth of Buy and Strong Buy ratings suggests growing confidence in Albemarle’s ability to capitalize on rising electric-vehicle demand and improved pricing dynamics.

In its latest quarter, Albemarle reported adjusted earnings per share of a loss of $0.19, outperforming the consensus by $0.73, on revenues of $1.31 billion, slightly above estimates. Year-over-year revenue declined 3.5%, but operating leverage in the lithium segment helped narrow losses. The company maintained a quarterly dividend of $0.405 per share, representing an annualized yield of approximately 1.0% and underscoring management’s commitment to returning cash to shareholders despite cyclical headwinds.